U.S. markets closed
  • S&P 500

    4,247.44
    +8.26 (+0.19%)
     
  • Dow 30

    34,479.60
    +13.40 (+0.04%)
     
  • Nasdaq

    14,069.42
    +49.12 (+0.35%)
     
  • Russell 2000

    2,335.81
    +24.40 (+1.06%)
     
  • Crude Oil

    70.78
    +0.49 (+0.70%)
     
  • Gold

    1,879.50
    -16.90 (-0.89%)
     
  • Silver

    28.05
    +0.02 (+0.07%)
     
  • EUR/USD

    1.2107
    -0.0071 (-0.58%)
     
  • 10-Yr Bond

    1.4620
    +0.0030 (+0.21%)
     
  • GBP/USD

    1.4117
    -0.0060 (-0.42%)
     
  • USD/JPY

    109.6350
    +0.2870 (+0.26%)
     
  • BTC-USD

    37,395.75
    +1,439.59 (+4.00%)
     
  • CMC Crypto 200

    924.19
    -17.62 (-1.87%)
     
  • FTSE 100

    7,134.06
    +45.88 (+0.65%)
     
  • Nikkei 225

    28,948.73
    -9.87 (-0.03%)
     

Abercrombie & Fitch To Sell CBD Products At 160 Stores

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Abercrombie & Fitch Co. (NYSE: ANF) will begin selling CBD products at more than 160 stores, the company said in a press release.

What Happened

Abercrombie initially tested CBD products made by Green Growth Brands Inc (OTC: GGBXF) at 10 stores in May and is ready to expand the relationship across more than 160 core Abercrombie & Fitch stores.

Abercrombie will sell CBD-infused body lotions, muscle balms, lip balms and sugar scrubs. Green Growth's products are made with CBD, which is derived from hemp and was made legal in late 2018. Supporters of CBD argue it can help with insomnia, pain and inflammation.

Why It's Important

Abercrombie is a brand that "understands how to connect" with its core customer both in the U.S. and internationally, said Green Growth Brands CEO Peter Horvath. Coupled with the company's "incredible" brand recognition, the CBD company is "excited at the prospect of building our partnership together."

Cannabis-focused research firm Brightfield Group as saying the CBD market could expand to a billion industry by 2022.

Need more cannabis news? Check out all of our coverage here.

Photo credit: Phillip Pessar, Flickr

See more from Benzinga

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.